Survey and Research Archives | Page 2 of 20 | Be Korea-savvy

Archive by category Survey and Research

PwC Study Shows Four Out of Five Executives Surveyed (84%) Report Blockchain Initiatives Underway

PwC Study Shows Four Out of Five Executives Surveyed (84%) Report Blockchain Initiatives Underway

LONDON, Aug. 28 (Korea Bizwire) — 84% of executives surveyed by PwC, report blockchain initiatives underway – 15% fully live. The new research from PwC – Blockchain is here. What’s your next move? – surveyed 600 executives in 15 countries and territories, on their development of blockchain and views on its potential. As blockchain rewires [...]

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

NEW YORK, Aug. 13 (Korea Bizwire) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that preliminary safety and efficacy data from a Phase 1/2 clinical trial of CK-101 (also known as RX518), a [...]

Neuralstem Announces NSI-189 Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Angelman Syndrome

Neuralstem Announces NSI-189 Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Angelman Syndrome

GERMANTOWN, Md., Aug. 9 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to NSI-189 for the treatment of Angelman syndrome. “Angelman Syndrome is a rare disease [...]

CORRECTING and REPLACING – Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-566 in Ischemic Stroke

CORRECTING and REPLACING – Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-566 in Ischemic Stroke

GERMANTOWN, Md., Aug. 1 (Korea Bizwire) — In a release issued yesterday by Neuralstem, Inc. (Nasdaq:CUR), please note the headline should be, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-566 in Ischemic Stroke,” rather than, “Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke,” as originally issued. The corrected release [...]

CUHK Business School Research Reveals How our Perceived Future Influences our Memories of the Past

CUHK Business School Research Reveals How our Perceived Future Influences our Memories of the Past

HONG KONG, CHINA, Jul. 31 (Korea Bizwire) – Vivid memories and emotions about things affect our perceptions of when they took place, but can the chance of them happening again also influence how we regard the past? Those of us who watched the Hollywood hit movie, La La Land, which focuses on a bitter-sweet love [...]

Neuralstem Announces Presentation of Preclinical Data Demonstrating Neurogenic Compound NSI-189 Improves Cognition and Anxiety in a Mouse Model of Alzheimer’s Disease

Neuralstem Announces Presentation of Preclinical Data Demonstrating Neurogenic Compound NSI-189 Improves Cognition and Anxiety in a Mouse Model of Alzheimer’s Disease

GERMANTOWN, Md., Jul. 23 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the presentation of data at the Alzheimer’s Association International Conference in Chicago, Illinois, demonstrating that oral administration of NSI-189 in a mouse model of Alzheimer’s Disease leads to a significant amelioration and/or improvement [...]

Allianz: Shipping Losses in Asia Buck Global Trends and Continues to Rise, Making it Top Region Worldwide for Major Shipping Incidents

Allianz: Shipping Losses in Asia Buck Global Trends and Continues to Rise, Making it Top Region Worldwide for Major Shipping Incidents

TOKYO/SEOUL, Jul. 23 (Korea Bizwire) – Large shipping losses have declined by 38% globally over the past decade, according to Allianz Global Corporate & Specialty’s (AGCS) Safety & Shipping Review 2018, with this downward trend continuing in 2017. However, disparities remain as losses in Asia rose year-on-year with incidents in South China, Indochina, Indonesia and Philippine [...]

Cryptomining Replaces Ransomware as Most Popular Cybercrime Malware

Cryptomining Replaces Ransomware as Most Popular Cybercrime Malware

SAN JOSE, Calif., Jul. 18 (Korea Bizwire) — Skybox® Security, a global leader in cybersecurity management, announced today the release of its mid-year update to the Vulnerability and Threat Trends Report which analyzes vulnerabilities, exploits and threats in play. The report, compiled by the team of security analysts at the Skybox® Research Lab, aims to help [...]

TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History

TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History

EDMONTON, Alberta, Jul. 9 (Korea Bizwire) — Translational Research In Oncology (TRIO) today announced a collaboration with Novartis on its upcoming phase III clinical trial of ribociclib with endocrine therapy in the adjuvant treatment of HR-positive, HER2-negative early breast cancer (EBC). The trial will be called NATALEE (New Adjuvant TriAl with LEE). “Ribociclib in combination [...]